SCHEMBL7868088

SCHEMBL7868088

COC=Cc1ccc(OC)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.64
CYP3A4 P08684 2/20 0.64
LMNA P02545 2/20 0.64
ALDH1A1 P00352 2/20 0.64
TP53 P04637 1/20 0.64
TSHR P16473 1/20 0.64
RELA Q04206 2/20 0.61
TRPA1 O75762 1/20 0.61
CYP1A2 P05177 3/20 0.59
CYP1A1 P04798 3/20 0.59
CYP1B1 Q16678 3/20 0.59
ESR1 P03372 2/20 0.59
PTGS2 P35354 2/20 0.59
TUBB4A P04350 2/20 0.59
TUBB P07437 2/20 0.59
TUBA3C P0DPH7 2/20 0.59
AHR P35869 2/20 0.59
TUBA1B P68363 2/20 0.59
TUBA4A P68366 2/20 0.59
TUBB4B P68371 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28662974 1.00 KDM4E (0.64) KDM4ECYP3A4LMNAALDH1A1TP53
SCHEMBL756486 0.86 KDM4E (0.64) KDM4ECYP3A4LMNAALDH1A1TP53
SCHEMBL8741689 0.86 KDM4E (0.46) KDM4ECYP3A4LMNAALDH1A1TP53
SCHEMBL6540540 0.85 PKM (0.66) KDM4ECYP3A4LMNAALDH1A1TP53
SCHEMBL6540537 0.85 PKM (0.66) KDM4ECYP3A4LMNAALDH1A1TP53
SCHEMBL631998 0.85 RELA (0.81) KDM4ECYP3A4LMNAALDH1A1TP53
SCHEMBL699458 0.85 RELA (0.81) KDM4ECYP3A4LMNAALDH1A1TP53
SCHEMBL13790336 0.85 RELA (0.81) KDM4ECYP3A4LMNAALDH1A1TP53
SCHEMBL4881152 0.85 RELA (0.81) KDM4ECYP3A4LMNAALDH1A1TP53
SCHEMBL14950253 0.85 RELA (0.81) KDM4ECYP3A4LMNAALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12285501-B2 Compound targeting norepinephrine transporter Higuchi, Takahiro (DE) 2025-04-29 US disclosed
US-20220096667-A1 Compound Targeting Norepinephrine Transporter Guangzhou Miphere Medical Technology Co., Ltd. (CN) 2022-03-31 US disclosed
US-10851237-B2 Block copolymer, multilayered structure, solid polymer membrane, fuel cell, method for producing multilayered structure, and method for producing multilayered structure including inorganic nanoparticles JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2020-12-01 US disclosed
US-20190169420-A1 BLOCK COPOLYMER, MULTILAYER STRUCTURE, SOLID POLYMER FILM, FUEL CELL, PRODUCTION METHOD FOR MULTILAYER STRUCTURE, AND PRODUCTION METHOD FOR MULTILAYER STRUCTURE CONTAINING INORGANIC NANOPARTICLES JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2019-06-06 US disclosed
WO-2001002417-A1 NUCLEOTIDE MONOMER CONTAINING SIX-MEMBERED AZARSUGAR AND ANTISENSE OLIGOMERS THEREOF DONGBU HANNONG CHEMICAL CO., LTD. (KR) 2001-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220096667-A1 Compound Targeting Norepinephrine Transporter SLC6A2, SLC18A2, SLC6A3 KDM4E 4165/4885CYP3A4 481/4885LMNA 2249/4885
US-12285501-B2 Compound targeting norepinephrine transporter SLC6A2, SLC18A2, SLC6A3 KDM4E 4165/4885CYP3A4 481/4885LMNA 2249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.